Restricting Mifepristone Access Could Empower Abusers
The 5th U.S. Circuit Court of Appeals heard arguments on Sept. 9 in Louisiana v. FDA, one of three cases threatening nationwide access to mifepristone, the medication used in the majority of abortions in the United States.





